0000000000372924

AUTHOR

Alberto Caminero

0000-0001-9555-7167

showing 5 related works from this author

Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity

2016

Background & Aims Partially degraded gluten peptides from cereals trigger celiac disease (CD), an autoimmune enteropathy occurring in genetically susceptible persons. Susceptibility genes are necessary but not sufficient to induce CD, and additional environmental factors related to unfavorable alterations in the microbiota have been proposed. We investigated gluten metabolism by opportunistic pathogens and commensal duodenal bacteria and characterized the capacity of the produced peptides to activate gluten-specific T-cells from CD patients. Methods We colonized germ-free C57BL/6 mice with bacteria isolated from the small intestine of CD patients or healthy controls, selected for their in v…

0301 basic medicineGlutensDuodenumTissue transglutaminaseT-Lymphocytesdigestive systemMicrobiologyMice03 medical and health sciencesLactobacillusmedicineAnimalsHumansImmunogenetic Phenomenachemistry.chemical_classificationHepatologybiologyImmunogenicityGastroenterologynutritional and metabolic diseasesmedicine.diseasebiology.organism_classificationGlutendigestive system diseasesSmall intestineAltered Schaedler floraMice Inbred C57BLCeliac DiseaseLactobacillus030104 developmental biologymedicine.anatomical_structurechemistryBacterial TranslocationCase-Control StudiesPseudomonas aeruginosaImmunologybiology.proteinGliadinDysbiosisGastroenterology
researchProduct

The Risk of Contracting COVID-19 Is Not Increased in Patients With Celiac Disease

2021

The World Health Organization declared coronavirus disease-2019 (COVID-19) a global pandemic in March 2020. Since then, there are more than 34 million cases of COVID-19 leading to more than 1 million deaths worldwide. Numerous studies suggest that celiac disease (CeD), a chronic immune-mediated gastrointestinal condition triggered by gluten, is associated with an increased risk of respiratory infections.(1-3) However, how it relates to the risk of COVID-19 is unknown. To address this gap, we conducted a cross-sectional study to evaluate whether patients with self-reported CeD are at an increased risk of contracting COVID-19.

AdultMalePediatricsmedicine.medical_specialtySettore MED/09 - Medicina InternaCoronavirus disease 2019 (COVID-19)coronavirusDiseasemedicine.disease_causeArticle03 medical and health sciencesDiet Gluten-Free0302 clinical medicineRisk FactorsSurveys and QuestionnairesPandemicOdds RatioMedicineHumansIn patientCoronavirusriskHepatologybusiness.industrySARS-CoV-2Case-control studyGastroenterologyCOVID-19Odds ratioinfectionCeliac Disease030220 oncology & carcinogenesisCase-Control Studiesgluten030211 gastroenterology & hepatologyGluten freeFemalebusiness
researchProduct

Lactobacilli Degrade Wheat Amylase Trypsin Inhibitors to Reduce Intestinal Dysfunction Induced by Immunogenic Wheat Proteins.

2019

Background & Aims Wheat-related disorders, a spectrum of conditions induced by the ingestion of gluten-containing cereals, have been increasing in prevalence. Patients with celiac disease have gluten-specific immune responses, but the contribution of non-gluten proteins to symptoms in patients with celiac disease or other wheat-related disorders is controversial. Methods C57BL/6 (control), Myd88–/–, Ticam1–/–, and Il15–/– mice were placed on diets that lacked wheat or gluten, with or without wheat amylase trypsin inhibitors (ATIs), for 1 week. Small intestine tissues were collected and intestinal intraepithelial lymphocytes (IELs) were measured; we also investigated gut permeability and int…

0301 basic medicineInflammationdigestive systemSensitivity and SpecificityGliadin03 medical and health sciencesDiet Gluten-FreeMiceRandom Allocation0302 clinical medicineImmune systemReference ValuesLactobacillusmedicineAnimalsHumansAmylaseTriticum2. Zero hungerchemistry.chemical_classificationToll-like receptorHepatologybiologybusiness.industryGastroenterologynutritional and metabolic diseasesbiology.organism_classificationGlutendigestive system diseasesSmall intestineImmunity Innate3. Good healthGastrointestinal MicrobiomeMice Inbred C57BLCeliac DiseaseDisease Models AnimalLactobacillus030104 developmental biologymedicine.anatomical_structurechemistryImmunologyAmylasesbiology.proteinIntraepithelial lymphocyte030211 gastroenterology & hepatologymedicine.symptombusinessTrypsin InhibitorsGastroenterology
researchProduct

Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG

2021

Background & Aims Many patients with irritable bowel syndrome (IBS) perceive that their symptoms are triggered by wheat-containing foods. We assessed symptoms and gastrointestinal transit before and after a gluten-free diet (GFD) in unselected patients with IBS and investigated biomarkers associated with symptoms. Methods We performed a prospective study of 50 patients with IBS (ROME III, all subtypes), with and without serologic reactivity to gluten (antigliadin IgG and IgA), and 25 healthy subjects (controls) at a university hospital in Hamilton, Ontario, Canada, between 2012 and 2016. Gastrointestinal transit, gut symptoms, anxiety, depression, somatization, dietary habits, and microbiot…

Diarrheamedicine.medical_specialtyAbdominal painConstipationGastroenterologyIrritable Bowel SyndromeDiet Gluten-Free03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansProspective StudiesIrritable bowel syndromechemistry.chemical_classificationCrohn's diseaseHepatologybusiness.industryGastroenterologymedicine.disease3. Good healthCeliac DiseaseDiarrheachemistryImmunoglobulin G030220 oncology & carcinogenesis030211 gastroenterology & hepatologyGluten freemedicine.symptombusinessFODMAPSomatizationClinical Gastroenterology and Hepatology
researchProduct

Risk perception and knowledge of COVID-19 in patients with celiac disease

2021

BACKGROUND We recently demonstrated that the odds of contracting coronavirus disease 2019 (COVID-19) in patients with celiac disease (CeD) is similar to that of the general population. However, how patients with CeD perceive their COVID-19 risk may differ from their actual risk. AIM To investigate risk perceptions of contracting COVID-19 in patients with CeD and determine the factors that may influence their perception. METHODS We distributed a survey throughout 10 countries between March and June 2020 and collected data on demographics, diet, COVID-19 testing, and risk perceptions of COVID-19 in patients with CeD. Participants were recruited through various celiac associations, clinic visi…

RiskMalemedicine.medical_specialtyPopulationObservational StudyDiseaseLogistic regressionOdds03 medical and health sciences0302 clinical medicineCOVID-19 TestingCeliac diseaseMedicineHumansCOVID-19 Celiac disease Coronavirus Gluten Infection Knowledge Perception RiskeducationAgededucation.field_of_studyCOVID-19; Celiac disease; Coronavirus; Gluten; Infection; Knowledge; Perception; Risk; Aged; COVID-19 Testing; Humans; Male; Perception; SARS-CoV-2; COVID-19; Celiac Diseasebusiness.industrySARS-CoV-2Public healthfungiGastroenterologyCOVID-19General MedicineOdds ratioMental healthRisk perceptionCoronavirusCeliac DiseaseKnowledge030220 oncology & carcinogenesis030211 gastroenterology & hepatologyPerceptionbusinessInfectionGlutenDemography
researchProduct